The Use of Thiopurine Derivatives in the Treatment of Inflammatory Bowel Disease

Basant    K.    Puri

« Previous Next »

[1] 
Penman ID, Lees CW.  In: Davidson's Principles and Practice of Medicine, 22nd ed. Walker, BR, Colledge, NR, Ralston, SH, Penman, ID, Eds.;
Churchill Livingstone/Elsevier: Edinburgh; New York, 2014, pp 837-920.
[2] 
McDowell C, Bhimji SS.  Treasure Island (FL), StatPearls Publishing; 2018.
[3] 
Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. Lancet  2018; 390: 2769-78.
[4] 
Cui G, Yuan A. A systematic review of epidemiology and risk factors associated with chinese inflammatory bowel disease. Front Med (Lausanne)  2018; 5: 183.
[5] 
Theochari NA, Stefanopoulos A, Mylonas KS, Economopoulos KP. Antibiotics exposure and risk of inflammatory bowel disease: A systematic review. Scand J Gastroenterol  2018; 53: 1-7.
[6] 
Gecse KB, Vermeire S. Differential diagnosis of inflammatory bowel disease: Imitations and complications. Lancet Gastroenterol Hepatol  2018; 3: 644-53.
[7] 
Shivashankar R, Lichtenstein GR. Mimics of inflammatory bowel disease. Inflamm Bowel Dis  2018; 24: 2315-21.
[8] 
Zhang H, Zeng Z, Mukherjee A, Shen B. Molecular diagnosis and classification of inflammatory bowel disease. Expert Rev Mol Diagn  2018; 18: 867-86.
[9] 
Masaki T, Kishiki T, Kojima K, Asou N, Beniya A, Matsuoka H. Recent trends (2016-2017) in the treatment of inflammatory bowel disease. Ann Gastroenterol Surg  2018; 2: 282-8.
[10] 
Panes J, Salas A. Past, present and future of therapeutic interventions targeting leukocyte trafficking in inflammatory bowel disease. J Crohn’s Colitis  2018; 12: S633-40.
[11] 
Su HJ, Chiu YT, Chiu CT, et al. Inflammatory bowel disease and its treatment in 2018: Global and Taiwanese status updates. J Formos Med Assoc  2018; 118(7): 1083-92.
[12] 
Trivedi PJ, Adams DH. Chemokines and chemokine receptors as therapeutic targets in inflammatory bowel disease; Pitfalls and Promise. J Crohns Colitis  2018; 12: S641-52.
[13] 
McIlroy J, Ianiro G, Mukhopadhya I, Hansen R, Hold GL. Review article: The gut microbiome in inflammatory bowel disease-avenues for microbial management. Aliment Pharmacol Ther  2018; 47: 26-42.
[14] 
Witkowski M, Witkowski M, Gagliani N, Huber S. Recipe for IBD: Can we use food to control inflammatory bowel disease? Semin Immunopathol  2018; 40: 145-56.
[15] 
Limketkai BN, Wolf A, Parian AM. Nutritional interventions in the patient with inflammatory bowel disease. Gastroenterol Clin North Am  2018; 47: 155-77.
[16] 
Rufino MN, Aleixo GFP, Trombine-Batista IE, et al. Systematic review and meta-analysis of preclinical trials demonstrate robust beneficial effects of prebiotics in induced inflammatory bowel disease. J Nutr Biochem  2018; 62: 1-8.
[17] 
Rahman SU, Li Y, Huang Y, et al. Treatment of inflammatory bowel disease via green tea polyphenols: Possible application and protective approaches. Inflammopharmacology  2018; 26: 319-30.
[18] 
de Boer NKH, Peyrin-Biroulet L, Jharap B, et al. Thiopurines in inflammatory bowel disease: New findings and perspectives. J Crohn’s Colitis  2018; 12: 610-20.
[19] 
Kakuta Y, Kinouchi Y, Shimosegawa T. Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: Prospects for clinical application of NUDT15 genotyping. J Gastroenterol  2018; 53: 172-80.
[20] 
Lu MJ, Qiu XY, Mao XQ, Li XT, Zhang HJ. Systematic review with meta-analysis: Thiopurines decrease the risk of colorectal neoplasia in patients with inflammatory bowel disease. Aliment Pharmacol Ther  2018; 47: 318-31.
[21] 
Vasudevan A, Beswick L, Friedman AB, et al. Low-dose thiopurine with allopurinol co-therapy overcomes thiopurine intolerance and allows thiopurine continuation in inflammatory bowel disease. Dig Liver Dis  2018; 50: 682-8.
[22] 
Wall GC, Muktar H, Effken C, Mahajan PB. Addition of allopurinol for altering thiopurine metabolism to optimize therapy in patients with inflammatory bowel disease. Pharmacotherapy  2018; 38: 259-70.

Rights & Permissions Print Cite

Article Metrics

22

3

1

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/157488711404191016121348	Print ISSN 1574-8871
Publisher Name Bentham Science Publisher	Online ISSN 1876-1038

Reviews on Recent Clinical Trials

The Use of Thiopurine Derivatives in the Treatment of Inflammatory Bowel Disease

Related Journals

Related Books